CAMBRIDGE, Mass., Feb. 1, 2024
/PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC)
today announced that it will host a live conference call and
webcast at 8:00 a.m. ET on Thursday,
February 15, 2024, to report its fourth quarter and full
year 2023 financial results and provide a corporate update.
To access the live conference call, please dial 833-470-1428
(domestic) or 404-975-4839 (international) and refer to conference
ID 071930. A webcast of the call will also be available under
"Events and Presentations" in the Investors & Media section of
the Blueprint Medicines website at
http://ir.blueprintmedicines.com/. The archived webcast will be
available on Blueprint Medicines' website approximately two hours
after the conference call and will be available for 30 days
following the call.
About Blueprint Medicines
Blueprint Medicines is a global precision therapy company
that invents life-changing medicines. Applying an approach that is
both precise and agile, we create therapies that selectively target
the root cause of disease, with the goal of staying one step ahead
across stages of disease. Since 2011, we have leveraged our
research platform, including expertise in molecular targeting and
world-class drug design capabilities, to rapidly and reproducibly
translate science into a broad pipeline of precision therapies.
Today, we have brought our approved medicines to patients
in the United States and Europe, and we are globally
advancing multiple programs for mast cell disorders, including
systemic mastocytosis and chronic urticaria, breast cancer and
other solid tumors. For more information,
visit www.BlueprintMedicines.com and follow us on
X (formerly Twitter; @BlueprintMeds) and LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-fourth-quarter-and-full-year-2023-financial-results-on-thursday-february-15-2024-302043757.html
SOURCE Blueprint Medicines Corporation